MASSDEVICE ON CALL —Medtronic (NYSE:MDT) CEO Omar Ishrak’s first year on the job netted him more than $25 million in salary, stock and bonuses that helped make up for the benefits he forfeited in order to take the jobs.
Ishrak received $1.2 million in salary in the fiscal year ended in April 2012, as well as nearly $1 million in non-equity incentive plan compensation.
He also landed nearly $5 million in stock and option awards and about $97,000 in "other" compensation, as well as $1.6 million in bonuses, $9.5 million in time-based stock awards and $6.8 million in performance-based stock awards, according to an SEC filing.
Q1 venture capital funding dropped 20% compared to previous quarter
Venture capitalists spent 20% less in the 1st quarter of 2012 than they did in the 4th quarter of 2011, and leaned harder toward late-stage deals. In medical device funding, VCs have begun looking for ground-breaking products rather than safe bets, firm managers told MassDevice in an exclusive podcast.
Survey finds Americans split on health reform ruling
A survey conducted by USA Today and Gallup found that 44% of participants were against the healthcare reform law upheld by the Supreme Court last week and 37% were in favor.
Med-tech tax: Still a chance for repeal
Citi analyst Matthew Dodds tells Bloomberg Businessweek that, despite the survival of the Affordable Care Act, device makers still have a chance to repeal the 2.3% medical device tax set to take effect next year.